Exploring the implications of modified risk claim placement in tobacco advertising

The United States Food and Drug Administration (FDA) has developed a regulatory process by which tobacco companies can apply to make “modified risk tobacco product” (MRTP) marketing claims that their product poses a lower risk of disease or exposure to harmful constituents. The impact of MRTP claims...

Descripción completa

Detalles Bibliográficos
Autores principales: Wackowski, Olivia A., Gratale, Stefanie K., Rashid, Mariam T., Greene, Kathryn, O'Connor, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684010/
https://www.ncbi.nlm.nih.gov/pubmed/34976664
http://dx.doi.org/10.1016/j.pmedr.2021.101608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684010/
https://www.ncbi.nlm.nih.gov/pubmed/34976664
http://dx.doi.org/10.1016/j.pmedr.2021.101608

Ejemplares similares